We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+6.3%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$31.9B
AUM Growth
+$1.95B
(+6.5%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$152M |
| 2 |
Ventas
VTR
|
+$139M |
| 3 |
Williams Companies
WMB
|
+$122M |
| 4 |
Healthpeak Properties
DOC
|
+$100M |
| 5 |
Chevron
CVX
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$276M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$110M |
| 3 |
Fortune Brands Innovations
FBIN
|
+$84.2M |
| 4 |
AGN
Allergan Inc
AGN
|
+$73.4M |
| 5 |
Morgan Stanley
MS
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.93% |
| 2 | Consumer Staples | 12.47% |
| 3 | Energy | 12.35% |
| 4 | Financials | 8.98% |
| 5 | Utilities | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMD
1326
DELISTED
Cantel Medical Corporation
CMD
| $559K | ﹤0.01% |
15,276
-6,427
| -30% | -$218K |
|
1327
U-Haul Holding Co
UHAL
$12.3B
| $555K | ﹤0.01% |
19,100
-20,290
| -52% | -$536K |
|
|
SHOR
1328
DELISTED
ShoreTel, Inc.
SHOR
| $550K | ﹤0.01% |
84,356
+989
| +1% | +$7.11K |
|
1329
Benchmark Electronics
BHE
$2.64B
| $549K | ﹤0.01% |
21,549
-16,906
| -44% | -$398K |
|
1330
Acco Brands
ACCO
$390M
| $547K | ﹤0.01% |
85,348
-102,141
| -54% | -$625K |
|
1331
Grand Canyon Education
LOPE
$4.02B
| $541K | ﹤0.01% |
11,767
+408
| +4% | +$18.4K |
|
1332
Globe Life
GL
$13.2B
| $535K | ﹤0.01% |
9,800
+6,297
| +180% | +$337K |
|
1333
Cimpress
CMPR
$1.98B
| $532K | ﹤0.01% |
13,137
-301
| -2% | -$13.1K |
|
1334
Intuitive Surgical
ISRG
$135B
| $532K | ﹤0.01% |
11,619
-117
| -1% | -$5.16K |
|
1335
Zimmer Biomet
ZBH
$18.4B
| $531K | ﹤0.01% |
5,262
-27,798
| -84% | -$2.71M |
|
1336
Alcoa
AA
$12.2B
| $529K | ﹤0.01% |
14,778
+9,344
| +172% | +$306K |
|
|
SEMI
1337
DELISTED
SunEdison Semiconductor Limited
SEMI
| $529K | ﹤0.01% |
+31,236
| New | +$514K |
|
1338
DTE Energy
DTE
$27.1B
| $526K | ﹤0.01% |
7,942
-4,078
| -34% | -$265K |
|
1339
Synaptics
SYNA
$3.52B
| $521K | ﹤0.01% |
5,744
+262
| +5% | +$17.8K |
|
1340
Warner Bros
WBD
$70.4B
| $520K | ﹤0.01% |
13,701
-35
| -0.3% | -$1.38K |
|
1341
Harley-Davidson
HOG
$2.8B
| $512K | ﹤0.01% |
7,339
+562
| +8% | +$39.6K |
|
1342
TechnipFMC
FTI
$28.4B
| $509K | ﹤0.01% |
11,202
-97
| -0.9% | -$4.11K |
|
1343
Progress Software
PRGS
$1.72B
| $509K | ﹤0.01% |
21,164
| – | – |
|
1344
Regions Financial
RF
$24.2B
| $507K | ﹤0.01% |
47,663
-10,179
| -18% | -$106K |
|
1345
J.M. Smucker
SJM
$13.2B
| $505K | ﹤0.01% |
4,735
+1,021
| +27% | +$102K |
|
|
SASR
1346
DELISTED
Sandy Spring Bancorp Inc
SASR
| $504K | ﹤0.01% |
20,230
-26
| -0.1% | -$628 |
|
1347
W&T Offshore
WTI
$586M
| $503K | ﹤0.01% |
30,711
| – | – |
|
1348
Hershey
HSY
$34.3B
| $501K | ﹤0.01% |
5,154
-3,556
| -41% | -$349K |
|
1349
American Vanguard Corp
AVD
$64M
| $499K | ﹤0.01% |
37,759
-1,151
| -3% | -$18.8K |
|
1350
Ionis Pharmaceuticals
IONS
$7.46B
| $498K | ﹤0.01% |
14,452
-16,372
| -53% | -$516K |
|
Similar funds
Federated Hermes's Q2 2014 Portfolio in Review
As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
- Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
- Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
- Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
- Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
- Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
- Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.
Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.